Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.380
-0.100 (-6.76%)
At close: Aug 13, 2025, 4:00 PM
1.380
0.00 (0.00%)
After-hours: Aug 13, 2025, 7:01 PM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.06 million as of August 13, 2025. Its market cap has increased by 0.46% in one year.
Market Cap
2.06M
Enterprise Value
-2.19M
1-Year Change
0.46%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $2.06M, a decrease of -96.95%. That is a compound annual growth rate of -60.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.21M | -17.81% |
| Dec 31, 2024 | 2.69M | 78.03% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |